Vanguard Group Inc Agenus Inc Transaction History

Vanguard Group Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.53 - $0.93 $2.19 Million - $3.84 Million	4,134,232 Added 13.66%	34,401,122 $20 Million
Q4 2023 Feb 14, 2024	BUY	$0.63 - $1.14 $2.1 Million - $3.79 Million	3,328,451 Added 12.36%	30,266,890 $25.1 Million
Q3 2023 Nov 14, 2023	BUY	$1.12 - $1.88 $484,066 - $812,539	432,202 Added 1.63%	26,938,439 $30.4 Million
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $3.77 Million - $5.87 Million	2,878,357 Added 12.18%	26,506,237 $42.4 Million
Q1 2023 May 15, 2023	SELL	$1.45 - $2.95 $947,393 - $1.93 Million	-653,375 Reduced 2.69%	23,627,880 $35.9 Million
Q4 2022 Feb 10, 2023	BUY	$2.02 - $3.25 $2.89 Million - $4.65 Million	1,430,085 Added 6.26%	24,281,255 $58.3 Million
Q3 2022 Nov 14, 2022	BUY	$1.96 - $3.14 $3.28 Million - $5.26 Million	1,673,615 Added 7.9%	22,851,170 $46.8 Million
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.64 $3.61 Million - $7.33 Million	2,775,146 Added 15.08%	21,177,555 $41.1 Million
Q1 2022 May 13, 2022	BUY	$2.35 - $3.47 $1.8 Million - $2.66 Million	767,856 Added 4.35%	18,402,409 $45.3 Million
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $7.88 Million - $15.5 Million	2,699,095 Added 18.07%	17,634,553 $56.8 Million
Q3 2021 Nov 12, 2021	BUY	$4.98 - $6.63 $5.14 Million - $6.84 Million	1,032,053 Added 7.42%	14,935,458 $78.4 Million
Q2 2021 Aug 13, 2021	BUY	$2.56 - $5.49 $35.6 Million - $76.3 Million	13,903,405 New	13,903,405 $76.3 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

Stay updated on Vanguard Group Inc with notifications on news.